Scientist tests Cancer-Killing virus on himself to watch immune system in action
NCT ID NCT07302945
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involved one healthy volunteer (the lead researcher) who gave himself a single dose of an experimental oncolytic virus called OTS-412. The goal was not to treat any disease but to closely monitor how the immune system responds immediately after the virus is given. Blood samples were taken over time to track changes in immune cells. This was a self-experiment to gather detailed immune data that is hard to capture in regular cancer patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pusan National University Medical college
Busan, 50612, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- First look: can a new drug candidate pass early safety tests in humans?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test
- Could a common drug shield the brain from Alzheimer's?